南京大学2017年生物化学二642真题.docVIP

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
南京大学2017年生物化学二642真题 蛋白质有哪些结构层次?阐述这些结构层次并说出维持每层结构的主要作用力(15分) 写出A型、B型、Z型DNA的主要特点及其之间的差异(15分) 某些植物的次生代谢物—羟基柠檬酸被用做减肥药物 (20分) 这种化合物能够抑制柠檬酸裂合酶的活性,你认为抑制属于哪一种形式? 为什么柠檬酸裂合酶活性的抑制能够阻止糖转变为脂肪? 你认为在体内还有哪些化合物的合成受到羟基柠檬酸的抑制?为什么? 写出三种碱性氨基酸、两种酸性氨基酸以及两种羟基氨基酸的结构式(20分) 试写出琼脂糖凝胶电泳与SDS的原理及差异(20分) 请阐述张峰(麻省理工大学)和韩春雨(河北科技大学)的主要工作。(20分) 总共8题,还有两题记不得了 生化与分子专业复试题目 写出一种生物学/药学方面的新技术,阐述其原理及应用(100分) 英文文献翻译(50分) The drug-resistant bacteria that pose the greatest health threats The World Health Organization (WHO) has for the first time released a list of drug-resistant bacteria that pose the greatest?threat to human health?— and for which new antibiotics are desperately needed. The agencys aim in listing these priority pathogens is to steer funds towards development of the most crucial antimicrobials. Researchers say the list is a useful reminder of the danger of bacteria that are becoming?resistant to antibiotics. The list ranks 12 bacteria or bacterial families and is topped by carbapenem-resistant?Acinetobacter baumannii. This obscure bacterium causes a severe infection for which almost no treatments exist, and mainly affects people who are already critically ill. (It is resistant to carbapenem antibiotics, a‘last resort’ antibiotic?used only when all other treatments have failed.) The ranking also includes well-known bacteria, such as those that cause pneumonia and gonorrhoea (see Threat list). Antibiotic resistance kills an estimated 700,000 people each year worldwide, and some experts predict that number to reach 10 million by 2050 if efforts are not made to?curtail resistance?or develop new antibiotics. Despite an urgent need for these drugs, the once-robust development pipeline for antibiotics now produces little more than a trickle of compounds. As of September 2016, about 40?new antibiotics?were in clinical development for the US market, compared with hundreds of cancer drugs. Many pharmaceutical companies see antibiotics as a losing proposition. “Most infections are still sensitive to

文档评论(0)

kolr + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档